Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator TherapyTomohisa Nezu, Ḱazunori Toyoda, Masatoshi Koga et al.|Stroke|2011Cited by 122
Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillationKoichiro Maeda, Ḱazunori Toyoda, Masatoshi Koga et al.|Journal of the Neurological Sciences|2011Cited by 33
Prior Anticoagulation and Short‐ or Long‐Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial FibrillationKeisuke Tokunaga, Masato Osaki, Ryo Itabashi et al.|Journal of the American Heart Association|2019Cited by 17
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA RegistryMasatoshi Koga, Ḱazunori Toyoda, Kazumi Kimura et al.|Journal of the Neurological Sciences|2011Cited by 14
Intravenous Alteplase at 0.6 mg/kg for Acute Stroke Patients with Basilar Artery Occlusion: The Stroke Acute Management with Urgent Risk Factor Assessment and Improvement (SAMURAI) Recombinant Tissue Plasminogen Activator RegistryTetsuya Miyagi, Ḱazunori Toyoda, Koichiro Maeda et al.|Journal of Stroke and Cerebrovascular Diseases|2012Cited by 10